Clinical Trials Logo

Clinical Trial Summary

This study is a retrospective, multicenter clinical study. The main objective is to analyze the risk factors affecting the recurrence of colorectal cancer patients with liver metastases who received radiofrequency/microwave ablation. Finally, we will construct a recurrence risk prediction model based on the risk factors and validated the model.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05268549
Study type Observational
Source The Central Hospital of Lishui City
Contact Zhongwei Zhao, Dr
Phone 15925728781
Email zhaozw79@163.com
Status Not yet recruiting
Phase
Start date March 12, 2022
Completion date August 12, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT03679039 - A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA